Medplus Health Services Share Price

NSE
MEDPLUS •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Medplus Health Services Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
52W high on Dec 06, 2024
10.3
TTM PE Ratio
High in industry
67.4
Price to Book Ratio
Above industry Median
5.4
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is less than 1
0.5

Medplus Health Services Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Medplus Health Services Ltd Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
1561.45 Cr
1576.17 Cr
1488.82 Cr
1490.5 Cr
1441.47 Cr

Medplus Health Services Ltd Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
5664.86 Cr
4603.65 Cr
3810.64 Cr
3090.81 Cr
2887.89 Cr

Medplus Health Services Ltd Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
45.87 Cr
38.7 Cr
14.34 Cr
33.56 Cr
13.7 Cr

Medplus Health Services Ltd Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
65.58 Cr
50.1 Cr
94.72 Cr
63.11 Cr
1.79 Cr
Medplus Health Services Ltd Result Highlights
  • Medplus Health Services Ltd reported a 0.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 8.5%.

  • Its expenses for the quarter were down by 1.5% QoQ and up 6.0% YoY.

  • The net profit increased 18.5% QoQ and increased 234.6% YoY.

  • The earnings per share (EPS) of Medplus Health Services Ltd stood at 3.8 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Medplus Health Services Ltd shareholding Pattern

Promoter
40.4%
Foreign Institutions
15.2%
Mutual Funds
21.5%
Domestic Institutions
25.7%
Public
18.7%
Promoter
40.4%
Foreign Institutions
14.7%
Mutual Funds
18.1%
Domestic Institutions
28%
Public
16.8%
Promoter
40.4%
Foreign Institutions
14.8%
Mutual Funds
12.2%
Domestic Institutions
22.2%
Public
22.5%
Promoter
40.4%
Foreign Institutions
14.9%
Mutual Funds
12.9%
Domestic Institutions
22.5%
Public
22.1%
Promoter
40.4%
Foreign Institutions
13%
Mutual Funds
15.4%
Domestic Institutions
25.2%
Public
21.3%
Promoter
40.4%
Foreign Institutions
12.4%
Mutual Funds
15.6%
Domestic Institutions
25.5%
Public
21.6%

Medplus Health Services Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
3
Bearish Moving Averages
13
5Day EMA
756.20
10Day EMA
761.50
12Day EMA
762.30
20Day EMA
766.90
26Day EMA
770.50
50Day EMA
774.10
100Day EMA
758.50
200Day EMA
739.50
5Day SMA
762.20
10Day SMA
773.10
20Day SMA
753.50
30Day SMA
774.20
50Day SMA
803.60
100Day SMA
750.10
150Day SMA
724.70
200Day SMA
717.00
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
78409 Rs
145259 Rs
Week Rs
116432 Rs
185071 Rs
Month Rs
144203 Rs
246914 Rs
Resistance & Support
740.65
Pivot
Resistance
First Resistance
756.25
Second Resistance
767.60
Third Resistance
783.20
Support
First Support
729.30
Second support
713.70
Third Support
702.35
Relative Strength Index
44.26
Money Flow Index
64.64
MACD
-8.20
MACD Signal
-9.17
Average True Range
32.78
Average Directional Index
32.22
Rate of Change (21)
-6.67
Rate of Change (125)
16

Medplus Health Services Ltd Company background

Founded in: 2006
MedPlus Health Services Limited was incorporated as a Private Limited Company with the name MedPlus Health Services Private Limited at Hyderabad on 30 November, 2006. The Company converted from a Private Limited Company to a Public Limited Company, pursuant to a Special Resolution passed by Shareholders at the Extra Ordinary General Meeting held on 01 June 2021 and name of the Company was changed to MedPlus Health Services Limited on 28 June 2021. The Company is engaged in providing pathological laboratory testing and manufacturing, trading and contract manufacturing of pharma, FMCG and beauty products and rendering of management services to group companies and holds investments in subsidiary companies. The Company has six direct subsidiaries and five stepdown subsidiaries.MedPlus is the second largest pharmacy retailer in India in terms of revenue and number of stores as of 31 March 2021.The company offer a wide range of products, including (i) pharmaceutical and wellness products, including medicines, vitamins, medical devices and test kits, and (ii) fastmoving consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers.The company grown from operating initial 48 stores in Hyderabad at the conception of the business to operating Indias second largest pharmacy retail network of over 2,000 stores distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal and Maharashtra, as of 31 March 2021.The number of stores has grown since the conception of the business and, as of 30 June 2021, MedPlus operated 520 stores in Karnataka, 458 stores in Tamil Nadu, 443 stores in Telangana, 274 stores in Andhra Pradesh, 201 stores in West Bengal, 186 stores in Maharashtra and 83 stores in Odisha.On 21 January 2021, the Company has issued and allotted 254674 equity shares of Rs 10 each as bonus shares to the shareholders in the ratio of 1.25:1.On 05 August 2021,the company has allotted 29910085 equity shares of Rs 2 each on conversion of preference shares.The allotment of 14,976,000 Equity Shares to Gangadi Madhukar Reddy upon conversion of 2,995,200 Series B CCPS held by it,6,660,575 Equity Shares to Agilemed Investments Private Limited upon conversion of 1,332,115 Series B1 CCPS held by it and 8,273,510 Equity Shares to Lone Furrow Investments Private Limited upon conversion of 1,654,702 Series B2 CCPS.During the month of December 2021,the company cameout with an Rs 1398.30crore public issue which comprised a fresh issue of Rs 600 crore and an offer for sale(OFS) of Rs 798.30 crore by selling shareholders.The IPO shares were allotted at the price of Rs 796 per share including a premium of Rs 794 per share.The net proceeds of the fresh issue will be utilised for funding working capital requirement of subsidiary,Optival and general corporate purposes.The allotted shares were listed on the BSE Ltd and National Stock Exchange of India Ltd(NSE) on 23 December 2021.During the year 202122, 747 stores were increased to the cluster store network of the Group. In March 2022, the Company launched its first Diagnostic Centre in Gachibowli, Hyderabad. It marked the presence with 2,748 Physical Stores during the year 2022.During the year 202223, 1144 stores were added to the cluster store network of the Company. As on March 31, 2023 the Companys total fleet of stores stood at 3822. The Company launched its Diagnostic Services Centre in the year 2021 as pilot project.During the year 202223, the Company incorporated a Subsidiary Company namely MedPlus Insurance Brokers Private Limited.
Read More

Medplus Health Services Ltd FAQs

Medplus Health Services Ltd share price is ₹744.9 in NSE and ₹744.35 in BSE as on 12/2/2025 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

Medplus Health Services Ltd share price in the past 1-year return was 21.63. The Medplus Health Services Ltd share hit a 1-year low of Rs. 598.6 and a 1-year high of Rs. 875.65.

The market cap of Medplus Health Services Ltd is Rs. 8915.99 Cr. as of 12/2/2025 12:00:00 AM.

The PE ratios of Medplus Health Services Ltd is 245.66 as of 12/2/2025 12:00:00 AM.

The PB ratios of Medplus Health Services Ltd is 7.36 as of 12/2/2025 12:00:00 AM

The Mutual Fund Shareholding in Medplus Health Services Ltd was 21.51% at the end of 12/2/2025 12:00:00 AM.

You can easily buy Medplus Health Services Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -